Office-Based Treatment of Venous Disease

Perspectives in Vascular Surgery and Endovascular Therapy

Volumn 18, Issue 4, 2006, Pages 306-310

  Mclafferty, Robert B ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ablation; phlebectomy; sclerotherapy; varicose veins; venous insufficiency

Indexed keywords

AMBULATORY CARE; CATHETER ABLATION; CHRONIC DISEASE; HEALTH CARE FACILITY; HUMAN; PATHOLOGY; REVIEW; SCLEROTHERAPY; VARICOSIS; VASCULAR SURGERY;

AMBULATORY CARE; CATHETER ABLATION; CHRONIC DISEASE; HUMANS; PHYSICIANS' OFFICES; SCLEROTHERAPY; VARICOSE VEINS; VASCULAR SURGICAL PROCEDURES;

EID: 34347260683     PISSN: 15310035     EISSN: None     Source Type: Journal    
DOI: 10.1177/1531003506297364     Document Type: Article

References (7)

1. Gloviczski P, Yao JST, eds. Handbook of Venous Disorders: Guidelines of the American Venous Forum. 2nd ed. London: Arnold; 2001:521-523.
2. Hussain S.M., McLafferty R.B., Passman M.A., et al. Establishment of a varicose vein center in a tertiary vascular surgery practice: urban versus rural differences. Ann Vasc Surg. 2006;20: 447-450.
3. Goldman M.P., Sadick N.S., Weis RA. Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy. Dermatol Surg. 1995;21: 19-29.
4. Cabrerra Garrido JR. E'largissement des limits de la sclero therapie: nouveaux produits sclerosants. Phlebologie. 1997;50: 181-188.
5. Tessari L. Nouvelle technique d'obtention de la scleromousse. Phlebologie. 2000;53: 129-133.
6. Forlee M.V., Grouden M, Moore D.J., Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg. 2006;43: 162-164.
7. Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg. 2002;28: 11-15.